Table 2

Studies investigating monotherapy of TNFi and non TNFi agents for the treatment of rheumatoid arthritis

Monotherapy superior to placeboMonotherapy at least comparable to MTX/DMARDsMonotherapy at least comparable to the agent plus MTX/DMARDs
TNFi agents